Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 28 04:00PM ET
102.22
Dollar change
-0.93
Percentage change
-0.90
%
Index- P/E14.31 EPS (ttm)7.14 Insider Own0.00% Shs Outstand2.04B Perf Week-0.33%
Market Cap208.94B Forward P/E13.27 EPS next Y7.70 Insider Trans- Shs Float2.04B Perf Month-5.31%
Income14.85B PEG1.60 EPS next Q1.67 Inst Own6.97% Short Float0.20% Perf Quarter4.58%
Sales49.78B P/S4.20 EPS this Y9.08% Inst Trans-8.78% Short Ratio2.82 Perf Half Y5.55%
Book/sh22.83 P/B4.48 EPS next Y9.16% ROA7.76% Short Interest4.12M Perf Year26.27%
Cash/sh7.06 P/C14.48 EPS next 5Y8.94% ROE16.52% 52W Range75.68 - 108.78 Perf YTD1.24%
Dividend Est.3.72 (3.64%) P/FCF15.59 EPS past 5Y5.63% ROI22.26% 52W High-6.03% Beta0.55
Dividend TTM3.31 (3.24%) Quick Ratio0.93 Sales past 5Y0.78% Gross Margin70.87% 52W Low35.06% ATR (14)1.31
Dividend Ex-DateMar 07, 2024 Current Ratio1.16 EPS Y/Y TTM125.94% Oper. Margin26.06% RSI (14)46.81 Volatility0.86% 1.07%
Employees76057 Debt/Eq0.56 Sales Y/Y TTM-1.51% Profit Margin29.83% Recom2.46 Target Price111.45
Option/ShortYes / Yes LT Debt/Eq0.43 EPS Q/Q502.21% Payout52.83% Rel Volume1.45 Prev Close103.15
Sales Surprise-3.88% EPS Surprise-7.31% Sales Q/Q-9.98% EarningsJan 31 BMO Avg Volume1.46M Price102.22
SMA20-0.28% SMA50-1.10% SMA2004.75% Trades Volume2,120,411 Change-0.90%
Date Action Analyst Rating Change Price Target Change
Feb-23-24Initiated BMO Capital Markets Market Perform $114
Jan-23-24Initiated Morgan Stanley Equal-Weight $114
Jan-16-24Resumed UBS Buy
Dec-18-23Downgrade HSBC Securities Buy → Hold
Sep-25-23Upgrade Morgan Stanley Underweight → Equal-Weight
Jul-14-23Initiated HSBC Securities Buy
Apr-26-23Upgrade Deutsche Bank Hold → Buy
Mar-27-23Upgrade Deutsche Bank Sell → Hold
Jan-26-23Downgrade Citigroup Buy → Neutral
Dec-05-22Upgrade Stifel Hold → Buy
Feb-28-24 06:00PM
10:27AM
Feb-27-24 08:00AM
Feb-23-24 05:43AM
Feb-22-24 09:21AM
04:13PM Loading…
Feb-15-24 04:13PM
Feb-14-24 03:21PM
08:00AM
Feb-10-24 08:30AM
Feb-06-24 11:16AM
10:29AM
04:30AM
04:23AM
01:40AM
Feb-05-24 06:54PM
06:47PM Loading…
06:47PM
06:35PM
05:44PM
05:30PM
04:55PM
04:52PM
04:45PM
Feb-04-24 05:50AM
Feb-02-24 08:52AM
Feb-01-24 01:23PM
11:55AM
Jan-31-24 04:05PM
03:56PM
02:30PM
01:50PM
12:50PM Loading…
12:50PM
11:47AM
11:00AM
10:48AM
09:30AM
09:09AM
05:17AM
05:14AM
05:08AM
03:40AM
01:58AM
01:16AM
01:00AM
Jan-30-24 06:24PM
07:59AM
Jan-29-24 11:00PM
02:03PM
Jan-26-24 09:15AM
Jan-24-24 11:39AM
04:27AM
Jan-22-24 08:34PM
08:11PM
06:00PM
07:00AM
Jan-19-24 04:43PM
10:00AM
07:09AM
Jan-18-24 06:15PM
12:11PM
Jan-17-24 05:07PM
10:15AM
Jan-16-24 07:43AM
Jan-12-24 06:00PM
06:09AM
05:27AM
Jan-11-24 06:15PM
04:22PM
04:05PM
12:54PM
12:47PM
12:30PM
Jan-10-24 07:15AM
03:54AM
Jan-09-24 01:41PM
01:14PM
12:42PM
01:21AM
Jan-08-24 05:14PM
04:42PM
04:08PM
03:25PM
02:12PM
01:11PM
01:05PM
06:29AM
01:15AM
Jan-07-24 02:31PM
12:51PM
Jan-05-24 06:00PM
03:33PM
02:20PM
02:20PM
09:23AM
09:15AM
Jan-02-24 06:15PM
04:07PM
01:51PM
08:36AM
07:36AM
07:14AM
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment includes researching, distributing and selling patented pharmaceuticals. The Sandoz segment focuses on marketing finished dosage form medicines and intermediary products including active pharmaceutical ingredients. The Corporate segment is involved in group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.